Insight Acquisition Corp.
INAQ-WT News Today: Stay Updated with the Latest Insight Acquisition Corp. News in Real Time
Find INAQ-WT news now at Meyka AI. Stay informed with the latest Insight Acquisition Corp. stocks updates, including price news, market analysis, and expert insights.
Earnings due 13 Mar 2026: GBM Resources (GBZ.AX ASX) pre-market view, cash focus
GBZ.AX stock: post-earnings pre-market check on cash, production outlook and Meyka AI forecast
157,000-share spike on close: Monitor 3738.T T-Gaia Corp JPX 12 Mar 2026
Volume spike highlights 3738.T stock on JPX with **157,000.00** shares; Meyka AI 12-month target JPY **3,200.00**
C$0.95 volume spike for PNC-B.TO Postmedia (TSX): monitor 37.10x rel volume
Intraday volume spike in PNC-B.TO stock at C$0.95 with 37.10x rel volume; quick Meyka AI forecast and risk-aware outlook
Intraday XETRA: Norden Crown Metals (03EA.F) +400% 12 Mar 2026: Check volume for follow-through
Intraday update on 03EA.F stock at EUR 0.0025 showing a 400% jump; volume, grade, and forecast
Tesla Energy Secures Approval to Supply Electricity in the UK
Tesla Energy has received official approval to supply electricity directly to consumers and businesses in the United Kingdom. The approval marks a major step forward in the company’s global renewable energy strategy. This move expands Tesla’s role beyond electric vehicles into broader electricity markets and clean energy infrastructure. The licensing from the UK energy regulator…
GT.SW volume spike Goodyear Tire (SIX) CHF9.00 12 Mar 2026: monitor liquidity shift
Intraday volume spike in GT.SW stock at CHF9.00 on 12 Mar 2026; quick liquidity and valuation check
SU.TO Suncor Energy (TSX) pre-market Mar 2026 C$79.10: heavy volume signals momentum
Pre-market SU.TO stock at C$79.10; PE 16.31, heavy volume; Meyka AI forecast and B+ grade for SU.TO stock
Spain’s Almirall in Talks With Dozens of Firms to License China Assets, CEO Says
Spain’s pharmaceutical leader Almirall is making waves in the global health sector. The company has publicly confirmed that it is in active talks with dozens of firms in China. The goal? To license China‑based medicines and assets to partners who can help commercialize them beyond the local market. This comes as the company strengthens its…
Migros Zürich Today, March 12: Sells Tegut to Edeka, Exits Germany
Swiss investors react as Migros Zürich Tegut sale to Edeka ends its Germany push, with losses up to €600m and antitrust review ahead. What it means for 2025.